Policy‐induced selection bias in pharmacoepidemiology: The example of coverage for Alzheimer's medications in British Columbia
Sign Up to like & getrecommendations! Published in 2019 at "Pharmacoepidemiology and Drug Safety"
DOI: 10.1002/pds.4804
Abstract: To assess the impact of a government‐sponsored reimbursement policy for cholinesterase inhibitors (ChEIs) on trends in physician visits with a diagnosis of Alzheimer's disease (AD). read more here.
Keywords: policy; selection bias; bias pharmacoepidemiology; induced selection ... See more keywords
Control yourself: ISPE‐endorsed guidance in the application of self‐controlled study designs in pharmacoepidemiology
Sign Up to like & getrecommendations! Published in 2021 at "Pharmacoepidemiology and Drug Safety"
DOI: 10.1002/pds.5227
Abstract: Consensus is needed on conceptual foundations, terminology and relationships among the various self‐controlled “trigger” study designs that control for time‐invariant confounding factors and target the association between transient exposures (potential triggers) and abrupt outcomes. The… read more here.
Keywords: self controlled; controlled study; control; pharmacoepidemiology ... See more keywords
Parity in female authorship in Australian pharmacoepidemiology research leveraging medicine dispensing data: How well are we doing?
Sign Up to like & getrecommendations! Published in 2022 at "Pharmacoepidemiology and Drug Safety"
DOI: 10.1002/pds.5450
Abstract: ‘ Exploring parity in female authorship of articles: A case study of the Canadian Network for Observational Drug Effect benchmark Australian pharmacoepidemiology research. read more here.
Keywords: pharmacoepidemiology research; parity female; female authorship; australian pharmacoepidemiology ... See more keywords
What is pharmacoepidemiology? Definition, methods, interest and clinical applications.
Sign Up to like & getrecommendations! Published in 2019 at "Therapie"
DOI: 10.1016/j.therap.2018.08.001
Abstract: Clinical evaluation of drugs before approval is based on the experimental design of clinical trial with randomization of drug exposure. Unfortunately, conclusions of clinical trials are necessarily limited to patients included into the trials. It… read more here.
Keywords: pharmacoepidemiology; methods interest; definition methods; clinical applications ... See more keywords
Pharmacoepidemiology for nephrologists: do proton pump inhibitors cause chronic kidney disease?
Sign Up to like & getrecommendations! Published in 2017 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfw349
Abstract: Abstract Pharmacoepidemiology studies are increasingly used for research into safe prescribing in chronic kidney disease (CKD). Typically, patients prescribed a drug are compared with patients who are not on the drug and outcomes are compared… read more here.
Keywords: chronic kidney; pharmacoepidemiology; proton pump; health ... See more keywords